スペソリマブを用いた過去の研究に参加した掌蹠膿疱症（PPP）患者におけるスペソリマブの長期治療を検証する研究

基本情報

NCT ID

NCT04493424

ステータス

中止

試験のフェーズ

第2相

試験タイプ

介入

目標被験者数

108

治験依頼者名

Boehringer Ingelheim

概要

This study is open to people with palmoplantar pustulosis who took part in previous clinical studies of a medicine called spesolimab. Participants who benefited from spesolimab treatment in the previous studies can join this study. The purpose of this study is to find out how safe spesolimab is and whether it helps people with palmoplantar pustulosis in the long-term. Participants are in this study for up to 5 years. During this time they visit the study site every month to get spesolimab injections under the skin. At study visits, doctors check the severity of participants' palmoplantar pustulosis and collect information on any health problems of the participants.

対象疾患

介入

依頼者（Sponsor）

実施施設 (23)